These results suggest that ADSCs, via the TGF-β1/SMAD3/ANGPTL4 axis, promote glycolysis and increase intraperitoneal dissemination in CRC cells in vivo (Fig. 8E). The gene discussed is TGFB1; the disease is colorectal carcinoma.